by Elizabeth Kissling | Apr 19, 2010 | Menopause, New Research, Newspapers, Pharmaceutical
Guest Post by Jerilynn C. Prior, Centre for Menstrual Cycle and Ovulation Research I just read “The Estrogen Dilemma” in Sunday’s New York Times Magazine, and I feel like weeping—in sorrow and deep sadness. This article by Cynthia Gorney is about energetic,...
by Elizabeth Kissling | Apr 3, 2010 | Birth Control, Menstruation, New Research, Pharmaceutical
We’ve mentioned Yaz and its sister drug Yasmin before, and our friend Holly Grigg-Spall tracks the progress of complaints against them and other oral contraceptives. Yaz and Yasmin were Bayer’s top-selling drugs in 2008, bringing in about $1.8 billion, a 17...
by Chris Bobel | Mar 31, 2010 | Advertising, Menstruation, New Research, Pharmaceutical
Today, there’s a front page story in the New York Times about Astra-Zeneca’s move to market their cholesterol pills (known as statins, and as the NYT reports, already the most prescribed drugs in the US) at healthy people in spite of unresolved concerns...
by Laura Wershler | Mar 18, 2010 | Birth Control, Health Care, New Research, Pharmaceutical
Women on the pill live longer. So touts a March 12, 2010 Reuters news story out of London, England reporting on a study published March 11 in the British Medical Journal (BMJ). A misleading headline if ever there was one. The study followed 46, 000 women for up to 40...
by Elizabeth Kissling | Feb 9, 2010 | Advertising, Birth Control, Law/Legal, Pharmaceutical
Guest Post from Evil Slutopia There are Tupperware parties, Passion Parties, Pampered Chef parties, and…Mirena IUD parties? Yes, apparently these events popped up early last year and were a joint effort from Bayer Pharmaceuticals and the mom marketing site Mom...